Funder
U.S. Department of Veterans Affairs
David Lynch Foundation
Reference41 articles.
1. Remyelination modulators in multiple sclerosis patients;Al-Temaimi;Experimental and molecular pathology,2017
2. Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination;Al Nimer;Neurology(R) neuroimmunology & neuroinflammation,2016
3. Altered mitochondrial and peroxisomal integrity in lipocalin-2-deficient mice with hepatic steatosis, biochimica et biophysica acta;Asimakopoulou;Molecular basis of disease,1863
4. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis;Berard;Glia,2012
5. T. Berger, A. Togawa, G.S. Duncan, A.J. Elia, A. You-Ten, A. Wakeham, H.E. Fong, C.C. Cheung, T.W. Mak, Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury, Proceedings of the National Academy of Sciences of the United States of America 103 (2006) 1834-1839.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献